Overview

China-Administration of Nicorandil Group(CHANGE)

Status:
Enrolling by invitation
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
We compared the infarct and edema size in ST-segment elevation acute myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI) treated by nicorandil before and after the reperfusion with those standard therapy treated by PCI
Phase:
Phase 4
Details
Lead Sponsor:
Chinese PLA General Hospital
Treatments:
Nicorandil